David Bautz
Analyst-Equity presso Zacks Investment Research, Inc. (Small Cap Research)
Profilo
Dr. David Bautz is a Senior Biotechnology Analyst at Zacks Investment Research, Inc. He joined the firm in February 2014.
Dr. Bautz worked for two years as a Research Associate at Human Genome Sciences, Inc., a biotechnology company that was eventually acquired by GlaxoSmithKline.
He obtained his PhD in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill in 2008.
His dissertation research focused on the characterization of autoantibodies in patients suffering from an orphan autoimmune disease.
He obtained his BS and MS degrees in Biochemistry from Virginia Tech.
Posizioni attive di David Bautz
| Società | Posizione | Inizio |
|---|---|---|
| Zacks Investment Research, Inc. (Small Cap Research) | Analyst-Equity | 01/02/2014 |
Formazione di David Bautz
| The University of North Carolina at Chapel Hill | Doctorate Degree |
| Virginia Polytechnic Institute & State University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
| Zacks Investment Research, Inc. (Small Cap Research) | Finance |
- Borsa valori
- Insiders
- David Bautz
